INSULIN GLARGINE U-300 – THE UNBRANDED
BIOLOGIC THAT IS IDENTICAL TO TOUJEO
Winthrop US is a Sanofi company dedicated to delivering unbranded versions of Sanofi products, including this unbranded biologic for TOUJEO.
Insulin glargine U-300 is an unbranded biologic for Toujeo, ensuring you have the same product experience as Toujeo.
- Insulin glargine U-300 uses the same manufacturing process as Toujeo
- It is identical to Toujeo in molecular weight distribution, quality control parameters, and inactive ingredients
LEARN MORE ABOUT WINTHROP
Winthrop, a Sanofi Company, is dedicated to ensuring patients get the same quality product they would from Sanofi’s brand name products. Winthrop products are identical to Sanofi products in molecular weight distribution, quality control parameters, inactive ingredients and other key factors. Quality, affordability, and service are the foundation of our relationship with patients and those that serve them.
What are Toujeo and Insulin Glargine U-300 injection?
Prescription Toujeo and Insulin Glargine U-300 are long-acting man-made insulins used to control high blood sugar in adults and children who are 6 years of age and older with diabetes mellitus.
- Toujeo and Insulin Glargine U-300 are not for the treatment of diabetic ketoacidosis
- It is not known if Toujeo and Insulin Glargine U-300 are safe and effective in children under 6 years of age
Important Safety Information for Toujeo U-300 (insulin glargine) injection
Important Safety Information for Toujeo and Insulin Glargine U-300
The Important Safety Information for Insulin Glargine U-300 is the same as for Toujeo.
Do not use Toujeo if you have low blood sugar or if you are allergic to insulin or any of the ingredients in Toujeo.
Do not share your pen(s) with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
Before starting Toujeo, tell your doctor about all your medical conditions, including if you have liver or kidney problems, if you are pregnant or planning to become pregnant, or if you are breastfeeding or planning to breastfeed.
Change (rotate) your injection sites within the area you chose with each dose to reduce your risk of getting pitted or thickened skin (lipodystrophy) and skin with lumps (localized cutaneous amyloidosis ) at the injection sites. Do not use the same spot for each injection or inject where the skin is pitted, thickened, lumpy, tender, bruised, scaly, hard, scarred, or damaged.
Heart failure can occur if you are taking insulin together with pills called TZDs (thiazolidinediones), even if you have never had heart failure or other heart problems. If you have heart failure, it may get worse while you take TZDs with Toujeo. Your treatment with TZDs and Toujeo may need to be changed or stopped by your doctor if you have new or worsening heart failure. Tell your doctor if you have any new or worsening symptoms including:
- Shortness of breath
- Sudden weight gain
- Swelling of your ankles or feet
Tell your doctor about all the medications you take, including OTC medicines, vitamins, and supplements, and herbal supplements.
Toujeo should be taken at the same time once a day. Test your blood sugar levels daily while using any insulin. Do not change your dose or type of insulin without talking to your doctor. Verify you have the correct insulin before each injection. Do NOT use a syringe to remove Toujeo from your pen. Your dose for Toujeo may be different from other insulins you have taken. Any change of insulin should be made cautiously and only under medical supervision.
Do NOT dilute or mix Toujeo with any other insulin or solution. It will not work as intended and you may lose blood sugar control, which could be serious. Use Toujeo only if the solution is clear and colorless with no particles visible.
While using Toujeo, do not drive or operate heavy machinery until you know how Toujeo affects you. Don’t drink alcohol or use other medicines that contain alcohol.
The most common side effect of Toujeo is low blood sugar (hypoglycemia), which may be serious and life-threatening. Severe hypoglycemia may cause harm to your heart or brain. Symptoms of serious low blood sugar may include shaking, sweating, fast heartbeat, and blurred vision. The long-acting effect of Toujeo may delay recovery from low blood sugar compared to shorter-acting insulins.
Toujeo may cause severe allergic reactions that can lead to death. Get medical help right away if you have:
- A rash over your whole body
- Shortness of breath
- Swelling of your face, tongue, or throat
- Extreme drowsiness, dizziness, or confusion
- Trouble breathing
- Fast heartbeat
Toujeo may have additional side effects including swelling, weight gain, low potassium, and injection site reactions which may include change in fat tissue, skin thickening, redness, swelling, and itching.
Toujeo and Insulin Glargine U-300 SoloStar and Toujeo and Insulin Glargine U-300 Max SoloStar are single-patient-use prefilled insulin pens. It is important to perform a safety test when using a new pen for the first time. Talk to your doctor about proper injection technique and follow instructions in the Instruction Leaflet that comes with your Toujeo SoloStar or Toujeo Max SoloStar pen.
Click here for Full Prescribing Information for Toujeo.
Click here for Full Prescribing Information for Insulin Glargine (U-300).
Click here for information on Sharps Medical Waste Disposal.
Click here to learn more about Sanofi's commitment to fighting counterfeit drugs.
If you are a patient experiencing problems with a Sanofi US product, please contact Sanofi US at 1-800-633-1610. 1-800-633-1610.
The health information contained herein is provided for general educational purposes only. Your healthcare professional is the single best source of information regarding your health. Please consult your healthcare professional if you have any questions about your health or treatment.
*Eligibility Restrictions & Offer Terms:
Insulins Valyou Savings Program: Sanofi insulins included in this program are: ADMELOG® (insulin lispro) injection 100 Units/mL, TOUJEO® SoloStar® U-300 (insulin glargine) injection 300 Units/mL, INSULIN GLARGINE SoloStar injection 300 Units/mL (U-300), TOUJEO® Max SoloStar® (insulin glargine) injection 300 Units/mL, INSULIN GLARGINE Max SoloStar injection 300 Units/mL (U-300), LANTUS® (insulin glargine) injection 100 Units/mL, INSULIN GLARGINE injection 100 Units/mL (U-100) and APIDRA® (insulin glulisine) injection 100 Units/mL.
Sanofi US Copay Program: This offer is not valid for prescriptions covered by or submitted for reimbursement under Medicare, Medicaid, VA, DOD, TRICARE, or similar federal or state programs including any state pharmaceutical assistance program. If you have an Affordable Care (Health Care Exchange) plan, you may still be qualified to receive and use this savings card. Please note: The Federal Employees Health Benefits (FEHB) Program is not a federal or state government healthcare program for purposes of the savings program. Void where prohibited by law. Sanofi reserves the right to rescind, revoke, terminate, or amend this program at any time without notice. Upon registration, patients will receive all program details.
• Toujeo or Insulin Glargine U-300 (Winthrop): Pay as low as $0 up to $99 for a 30-day supply. Amount depends on insurance coverage. Valid up to 10 packs per fill; offer valid for 1 fill every thirty days.
Savings may vary depending on patients’ out-of-pocket costs. Upon registration, patients receive all program details. Sanofi US reserves the right to change the maximum cap amount, rescind, revoke or amend these programs without notice.